scholarly journals Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multicenter Study

2018 ◽  
Vol 9 (5) ◽  
pp. 2067-2079 ◽  
Author(s):  
Natsu Otowa-Suematsu ◽  
Kazuhiko Sakaguchi ◽  
Tomoaki Nakamura ◽  
Kenta Hara ◽  
Minoru Kishi ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Combination Therapy ◽  
Multicenter Study ◽  
Basal Insulin ◽  
Comprehensive Evaluation ◽  
Japanese Patients ◽  
Open Label ◽  
Parallel Group

scholarly journals Safety, tolerability and efficacy of lixisenatide as monotherapy in Japanese patients with type 2 diabetes mellitus: An open-label, multicenter study

2017 ◽  
Vol 9 (1) ◽  
pp. 108-118 ◽  
Author(s):  
Yutaka Seino ◽  
Yasuo Terauchi ◽  
Xiangling Wang ◽  
Daisuke Watanabe ◽  
Elisabeth Niemoeller ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Multicenter Study ◽  
Japanese Patients ◽  
Open Label

scholarly journals Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36‐week, randomized, double‐blind, parallel‐group trial

2016 ◽  
Vol 7 (4) ◽  
pp. 565-573 ◽  
Author(s):  
Yutaka Seino ◽  
Shizuka Kaneko ◽  
Shuichi Fukuda ◽  
Takeshi Osonoi ◽  
Toshihiko Shiraiwa ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Combination Therapy ◽  
Japanese Patients ◽  
Double Blind ◽  
Parallel Group ◽  
Parallel Group Trial ◽  
Group Trial

scholarly journals Dapagliflozin as Monotherapy or Combination Therapy in Japanese Patients with Type 2 Diabetes: an Open-Label Study

2014 ◽  
Vol 5 (2) ◽  
pp. 415-433 ◽  
Author(s):  
Kohei Kaku ◽  
Hiroshi Maegawa ◽  
Yukio Tanizawa ◽  
Arihiro Kiyosue ◽  
Yumiko Ide ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Combination Therapy ◽  
Japanese Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study
Sign in / Sign up

Export Citation Format

Share Document